Our people

"By overcoming biological barriers which have previously prevented drug delivery, we are now bringing new drug modalities, such as peptides, proteins, antisense oligonucleotides and mRNA, to the clinic."

Annette Bak, Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D

View Annette's profile

Our people

"Although significant advances have been made, we still need to work on not just the treatment of chronic lung disease but also on disease modification and cure."

Maria Belvisi, Senior Vice President and Head of Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D

View Maria's profile

Our people

"New digital technologies are allowing us to reimagine healthcare and improve patient experiences and outcomes, allowing us to reinvent clinical trials, select study populations that better reflect real-world demographics, and enabling us to minimise research disruption during a pandemic. "

Cristina Durán, Chief Digital Health Officer, R&D

View Cristina 's profile

Our people

"We recently got some exciting data on cardiomyocyte proliferation, where we showed that our modRNA molecules and some small molecules we identified through phenotypic screening could proliferate human cardiomyocytes."

Regina Fritsche-Danielson, Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

View Regina 's profile

Our people

"I am passionate about developing medicines to improve the outcomes for patients with cancer and developing the skills and experience of the people within my team.".

Susan Galbraith, Senior Vice President and Head of Research and Early Development, Oncology R&D

View Susan's profile

Our people

"I am passionate about bringing the patient voice to everything we do at AstraZeneca. Understanding the patient experience is what has guided me as a practicing physician, in teaching medicine and in my 35 years in exploratory research and early clinical development".

Ann E. Taylor, Chief Medical Officer

View Ann's profile

Alan Sabirsh

Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Alicyn Campbell

Head of Digital Health, Oncology R&D

Amy Taylor

Business Planning & Operations Director, Chief Operating Office, BioPharmaceuticals R&D

Anand Subramony

Vice President, Antibody Discovery and Protein Engineering, R&D

Anas Younes

Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D

Anders Broo

Head of Data Science and Modelling, Pharmaceutical Sciences, R&D

Andrea Burgos Prieto

Associate Director Alliance & Integration Management, Business Development Operations

Andrew Foxley

Vice President, Franchise Head, Late Oncology R&D

Ann E. Taylor

Chief Medical Officer

Anna Sundgren

Global Development Leader, Lokelma & Bydureon

Annette Bak

Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Arpan Desai

Associate Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Åsa Sjöholm Timén, PhD

Associate Transaction Director, Business Development Operations

Ashiq Ariff

Data Scientist

Ashling Mulvaney

VP Sustainability, Access to Healthcare & Healthy Heart Africa

Barry Davies

Global Project Leader, Oncology Combinations, Early Oncology

Carlos Doti

Global Medical Affairs Head, Hematology and Ad Interim US Hematology Franchise Head, Medical Affairs

Caroline Germa

Vice President, Head Clinical Development, Early Portfolio, Oncology R&D

Chris Kenny

Senior Information Architect

Christopher J. Rhodes

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme

Clive Green

Executive Director and Head of Global Sample Management, Discovery Sciences, R&D

Cristian Massacesi

Senior Vice President, Head of Late Stage Development Oncology

Cristina Durán

Chief Digital Health Officer, R&D

Daniel Freeman

Vice President of Early Development Oncology

David Geleta

Data Scientist

David Keeling

Senior Project Leader, Research and Early Development, Respiratory, Inflammation & Autoimmunity, BioPharmaceuticals R&D

Elisa Lázaro Ibáñez

Postdoctoral Researcher, Discovery Biology, Discovery Sciences, R&D

Elisabeth Björk

SVP, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Ella Ekholm

Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Esben Jannik Bjerrum

Principal Scientist, Cheminformatics, Discovery Sciences, R&D

Eva Yin

General Manager, Oncology Business Unit

Ezogelin Oflazoglu-Gruyters

Vice-President, Head of External R&D and Strategic Alliances, Oncology R&D

Fredrik Röök

Transaction Director, Business Development Operations

Jason Snape

Global Head of Environmental Protection

Jim Weatherall

Vice President, Data Science & AI, R&D

John Houghton

Global Franchise Head, Roxadustat

Joris Silon

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit

Kiran Nistala

VP and Head of Clinical Development, Immunology, Respiratory & Immunology Late-stage Development

Kirsha Naicker

Global Study Medical Scientist Leader, Immuno-oncology

Lennart Lindfors

Adjunct Professor and Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Leora Horn

Global Clinical Head for Lung Cancer and Lung Cancer Strategy

Li-Ming Gan

Head of Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Lutz Jermutus

Head of Projects

Magnus Johansson

Principal Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Malin Lemurell

Senior Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Maria Belvisi

Senior Vice President and Head of Research and Early Development, Respiratory, Inflammation and Autoimmunity, BioPharmaceuticals R&D

Maria Groves

Associate Director, Head of the Cancer Research UK – AstraZeneca Antibody Alliance Laboratory (CAZAAL)

Marianne Ashford

Senior Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Mark Cobbold

Vice President, Discovery, Oncology R&D

Mark O’Connor

Chief Scientist, Early Oncology Discovery

Menelas Pangalos

Executive Vice-President, BioPharmaceuticals R&D

Mika Sovak

Vice President and Franchise Head, R&D, AstraZeneca

Miriam Guest

Associate Principal Scientist, Microbiology, Pharmaceutical Technology and Development

Nicolas Jose Guzman

Director Physician, Nephrology Clinical Research

Ola Engkvist

Associate Director, Computational Chemistry, Discovery Sciences, R&D

Paul Harper

Principal Scientist, Discovery Sciences, R&D

Per Alfredsson

Senior Vice President, Global Biologics Operations

Per Lindblom

Director, Global Project Management

Priti Patel

Vice President, Clinical Development, Haematology

Puja Sapra

Vice President, Tumour Targeted Delivery, Early Oncology

Qing-Dong Wang

Senior Principal Scientist, Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Ralph Knöll

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Regina Fritsche-Danielson

Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Renee Bailey Iacona

Vice President, Oncology Biometrics, Oncology R&D

Richard Marshall

Senior Vice President and Global Head of Respiratory & Immunology Late Stage Development, BioPharmaceuticals R&D

Ruth March

Senior Vice-President of Precision Medicine, R&D Oncology

Sanya Puri

Associate Director, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Sara Richardson

New Modality CMC Analytics Team Lead, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Serban Ghiorghiu

Vice President, Clinical Development, Late Development Oncology R&D

Shawn Davis

Head of Drug Delivery, BioPharmaceuticals Development, R&D

Shin Morita

Vice President, Oncology Business Unit

Simon Bradford

Data & Analytics Enabling Units Engineering Lead

Slavé Petrovski

VP, Head of Centre for Genomics Research, Discovery Sciences, R&D

Stephen Delaney

Team Leader, Research and Early Development, Respiratory, Inflammation & Autoimmunity (RIA), BioPharmaceuticals R&D

Steve Rees

VP, Discovery Biology, Discovery Sciences, R&D

Stewart Owen

Principal Environmental Scientist

Sunil Verma

Vice President, Global Clinical Head, Breast Cancer and Head of Breast Cancer Research Strategy

Susan Galbraith

Senior Vice President and Head of Research and Early Development, Oncology R&D

Teresa Klinowska

Global Product Leader, AZD9833

Ti Hwei How

Vice President, International Oncology

Tonya Villafana

Vice President, Global Franchise Head, Infection

Tom Keith-Roach

President, AstraZeneca UK

Umaima Ahmad

Associate Transaction Director, Business Development Operations

William Dall’Acqua

Vice President, Antibody Discovery and Protein Engineering, R&D

Regina Fritsche-Danielson

Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

View Regina's profile

Mark O’Connor

Chief Scientist, Oncology

View Jonathan's profile

Ruth March

Senior Vice-President of Precision Medicine, R&D Oncology

View Ruth's profile

Menelas Pangalos

Executive Vice-President, BioPharmaceuticals R&D

View Menelas's profile

Fredrik Röök

Transaction Director, Business Development Operations

View Fredrik's profile

Our therapy areas

Cardiovascular, Renal and Metabolism

Oncology

Respiratory & Immunology

Neuroscience

Infection and Vaccines